Applied Spine Technologies Launches New Corporate Website

Share this story with your network

Applied Spine Technologies Inc. a medical device company focused on motion preservation of the lumbar spine, today announced the launch of their new website design at www.appliedspine.com. As part of the company’s practice to increase awareness of their Stabilimax® Dynamic Spine Stabilization System, the new design will help foster more open communication with patients suffering from back pain.

“As a consequence of recent IP grants, Applied Spine is able to share a broader range of information with patients and physicians wishing to learn more about the Stabilimax System, the composition of the technology, and our ongoing multi-center IDE clinical trial,” states Craig Corrance, CEO of Applied Spine.

A notable new feature of the website is a three scene animation depicting the functional aspects of the Stabilimax System from both an engineering and biomechanical perspective. “Stabilimax is a very sophisticated device, but unless deconstructed, it is challenging to explain,” said Ed Durkin, marketing consultant for Applied Spine. “Portraying the device in simultaneous motion represents a new approach to sharing characteristics of the Stabilimax System, particularly the function of the dual-spring design allowing for near-normal kinematic motion and measurable interpedicular travel.”

For the general public, especially those with chronic back pain due to spinal stenosis, the site offers an enhanced interactive questionnaire to help determine if they may indeed be a candidate to participate in the clinical trial. Patients who qualify have the opportunity to be referred to the nearest clinical study investigational site for consultation with a spine surgeon.

About Applied Spine Technologies Inc., and Stabilimax®

Applied Spine Technologies Inc., headquartered in Rocky Hill, Connecticut, is developing the Stabilimax Dynamic Spine Stabilization System, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. Stabilimax is expected to offer numerous advantages over current spinal fixation products and even new artificial disc products—including a much less invasive and less traumatic implant procedure, maintenance of spine motion and disc function, and the potential to prevent or slow adjacent-segment disc disease.

About the IDE Clinical Trial

Applied Spine Technologies, Inc. is currently conducting a multi-center, randomized, controlled clinical trial in the U.S. to compare posterior dynamic stabilization using the Stabilimax Dynamic Spine Stabilization System to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis. AST has enrolled more than 100 patients to date.

Stabilimax is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only

Leave a Comment

Your email address will not be published. Required fields are marked *

*